P3 Health Partners Inc.(PIII)

Medical - Care Facilities · Henderson, NV

$6.01-0.17 (-2.67%)

Delayed quote: Oct 6, 2026, 12:49 PM EDT

P3 Health Partners (PIII) PE Ratio: History & Chart | TGMCharts

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T17:33:38.182Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:33:38.182Z.

Quote observation: 2026-10-06T16:49:17.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 6.005
Unrounded diluted TTM EPS · period ending 2026-06-30: -32.95

FMP input reference: ac2c7a41ad5640622b079511a65f3d79aa9aa97fd30809e3a9f0c7038551df0a

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

PIII PE Ratio Metrics

PE RATIO

N/A

PIII Competitors' PE Ratio

PIII

P3 Health Partners Inc.

Current

Market Cap

$19.67M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NXTC

NextCure, Inc.

vs PIII

Market Cap

$19.51M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACTU

Actuate Therapeutics Inc

vs PIII

Market Cap

$19.43M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEUP

Neuphoria Therapeutics Inc.

vs PIII

Market Cap

$18.67M

PE Ratio

N/A

TTM Avg

2.38

3Y Avg

2.38

5Y Avg

2.38

MODD

Modular Medical, Inc.

vs PIII

Market Cap

$21.03M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QNTM

Quantum BioPharma Ltd.

vs PIII

Market Cap

$21.24M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ESLA

Estrella Immunopharma, Inc.

vs PIII

Market Cap

$17.87M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COSM

Cosmos Health Inc.

vs PIII

Market Cap

$17.58M

PE Ratio

N/A

TTM Avg

49.08

3Y Avg

49.08

5Y Avg

49.08

LONA

LeonaBio, Inc.

vs PIII

Market Cap

$22.36M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LPCN

Lipocine Inc.

vs PIII

Market Cap

$17.15M

PE Ratio

N/A

TTM Avg

29275707116178676.00

3Y Avg

6105628756850110.00

5Y Avg

6105628756850110.00

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
P3 Health Partners Inc. (PIII)	$19.67M	N/A	N/A	N/A	N/A
NextCure, Inc. (NXTC)vs ›	$19.51M	N/A	N/A	N/A	N/A
Actuate Therapeutics Inc (ACTU)vs ›	$19.43M	N/A	N/A	N/A	N/A
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.67M	N/A	2.38	2.38	2.38
Modular Medical, Inc. (MODD)vs ›	$21.03M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$21.24M	N/A	N/A	N/A	N/A
Estrella Immunopharma, Inc. (ESLA)vs ›	$17.87M	N/A	N/A	N/A	N/A
Cosmos Health Inc. (COSM)vs ›	$17.58M	N/A	49.08	49.08	49.08
LeonaBio, Inc. (LONA)vs ›	$22.36M	N/A	N/A	N/A	N/A
Lipocine Inc. (LPCN)vs ›	$17.15M	N/A	29275707116178676.00	6105628756850110.00	6105628756850110.00

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$6.00

Forward EPS (Est.)

$-7.27

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

PIII PE Ratio Metrics

PIII Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics